First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings-Reference-Cited by-同舟云学术

First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings

Published:2021-01 Issue: Volume:157 Page:103198
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Ferro Matteo,Lucarelli Giuseppe,Crocetto Felice,Dolce Pasquale,Verde Antonio,La Civita Evelina,Zappavigna Silvia,de Cobelli Ottavio,Di Lorenzo Giuseppe,Facchini Bianca Arianna,Scafuri Luca,Onofrio Livia,Porreca Angelo,Busetto Gian Maria,Sonpavde Guru,Caraglia Michele,Klain Michele,Terracciano Daniela,De Placido Sabino,Buonerba Carlo

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference29 articles.

1. Arches: a randomized, phase III study of androgen deprivation therapy with enzalutamide or placebo in men with metastatic hormone-sensitive prostate cancer;Armstrong;J. Clin. Oncol.,2019

2. Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: a systematic review and meta-analysis;Buonerba;Crit. Rev. Oncol. Hematol.,2020

3. Apalutamide for metastatic, castration-sensitive prostate cancer;Chi;N. Engl. J. Med.,2019

4. Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial;Clarke;Ann. Oncol.,2019

5. Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: a position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO);D’Angelillo;Crit. Rev. Oncol. Hematol.,2019

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. To eat or not to eat: a critical review on the role of autophagy in prostate carcinogenesis and prostate cancer therapeutics;Frontiers in Pharmacology;2024-06-07

2. Role of extracellular vesicles in castration-resistant prostate cancer;Critical Reviews in Oncology/Hematology;2024-05

3. Efficacy of Treatment for Metastatic Hormone-Sensitive Prostate Cancer: An Umbrella Review of Systematic Reviews and Meta-Analyses;Cancers;2023-12-06

4. The Role of Alpha Therapy in Metastatic Castration Resistance Prostate Cancer;Nuclear Medicine Seminars;2023-09-01

5. The Prognostic Nutritional Index (PNI): A New Biomarker for Determining Prognosis in Metastatic Castration-Sensitive Prostate Carcinoma;Journal of Clinical Medicine;2023-08-22